Although the efficacy of MTX on vasculo-BD has not been established, the combination therapy with anti-TNF-α agents seemed to be effective in other BD-related vasculitis including retinal and entero-vasculitis [14], suggesting MTX can also be a reasonable immunosuppressive agent for vasculo-BD. This evidence concerns the gene TNF and vasculitis.